Localized Cutaneous Leishmaniasis
📧 Sign up to get email alerts when something new happens for Localized Cutaneous Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR). [Phase 2]
A Phase 2 clinical trial is evaluating two LXE408 oral regimens versus miltefosine as an active control to assess efficacy, safety, and phar…
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients [Phase 4]
Phase 4 trial evaluating low-dose meglumine antimoniate (pentavalent antimony) for localized cutaneous leishmaniasis in older adults has com…